Recommendations for the diagnosis of paroxysmal nocturnal hemoglobinuria: A German-Austrian consensus;Empfehlungen zur Diagnostik der Paroxysmalen nächtlichen Hämoglobinurie: deutsch - österreichischer Konsensus

LaboratoriumsMedizin

Volumn 35, Issue 6, 2011, Pages 315-327

  Schrezenmeier, Hubert ^a   Bettelheim, Peter ^b   Panse, Jens ^c   Schubert, Jörg ^d   Höchsmann, Britta ^a   Röth, Alexander ^e   Nebe, Thomas ^f  

^a UNIVERSITY OF ULM   (Germany)

^b ELISABETHINEN HOSPITAL   (Austria)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d Evangelisches Krankenhaus Hamm gGmbH   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f MVZ Onkologikum Frankfurt Am Main ^*  (Germany)

Author keywords

flow cytometry; German Austrian consensus; GPI anchored proteins; immunophenotyping; paroxysmal nocturnal hemoglobinuria; stepwise diagnosis

Indexed keywords

ALGORITHM; ARTICLE; AUSTRIA; CONSENSUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; FEASIBILITY STUDY; GERMANY; HUMAN; IMMUNOPHENOTYPING; MEDICAL TECHNOLOGY; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRACTICE GUIDELINE; SCREENING; TREATMENT INDICATION;

EID: 81055147767     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/JLM.2011.060     Document Type: Article

References (42)

1. Les Cahiers d'Orphanet; November 2008;1:2-26.
2. Hill A, Ridley SH, Esser D, Oldroyd RG, Cullen MJ, Kareclas P, et al. Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy. Blood 2006;107:2131-7. (Pubitemid 43289399)
3. Socie G, Mary J Y, de GA, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996;348:573-7. (Pubitemid 26283888)
4. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie J V. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-8.
5. de Latour PR, Mary J Y, Salanoubat C, Terriou L, Etienne G, Mohty M, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 2008;112:3099-106.
6. Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 2008;111:1840-7. (Pubitemid 351451491)
7. Johnson RJ, Hillmen P. Paroxysmal nocturnal haemoglobinuria: nature's gene therapy? Mol Pathol. 2002;55:145-52. (Pubitemid 34620763)
8. Luzzatto L, Gianfaldoni G. Recent advances in biological and clinical aspects of paroxysmal nocturnal hemoglobinuria. Int J Hematol 2006;84:104-12. (Pubitemid 44343971)
9. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 1999;96:5209-14. (Pubitemid 29214562)
10. Bessler M, Mason PJ, Hillmen P, Luzzatto L. Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1994;87:863-6. (Pubitemid 24264666)
11. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. J Am Med Assoc 2005;293:1653-62. (Pubitemid 40471796)
12. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. For International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;106:3699-709. (Pubitemid 41739003)
13. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996;87:5332-40. (Pubitemid 26189877)
14. Galili N. Prevalence of paroxysmal nocturnal hemoglobinuria (PNH) cells in patients with myelodyplastic syndromes (MDS), aplastic anemia (AA) or other bone marrow failure syndromes (BMF): interim results from the EXPLORE trial. J Clin Oncol. 2009; 27(suppl.):7082.
15. Saso R, Marsh J, Cevreska L, Szer J, Gale RP, Rowlings PA, et al. Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Brit J Haem 1999;104:392-6. (Pubitemid 29083350)
16. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355:1233-43. (Pubitemid 44427447)
17. Hillmen P, Muus P, Duhrsen U, Risitano AM, Schubert J, Luzzatto L, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007;110:4123-8. (Pubitemid 350248472)
18. Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L. Discovery and development of the complement inhibitor eculi-zumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol 2007;25:1256-64. (Pubitemid 350076509)
19. Röth A, Dührsen U, Schrezenmeier H, Schubert J. Paroxysmale nächtliche Hämoglobinurie (PNH)-Pathogenese, Diagnostik und Therapie. Dtsch med Wochenschr 2009;134:404-9.
20. Schrezenmeier H, Höchsmann B. Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria. Expert Rev Hematol 2009;2:7-16.
21. Späth-Schwalbe E, Schrezenmeier H, Heimpel H. Paroxysmale nächtliche Hämoglobinurie: Klinische Erfahrungen bei 40 Patienten in einem Zentrumüber 25 Jahre. Dtsch med Wochenschr 1995;120:1027-33.
22. Borowitz M, Craig F, DiGuiseppe J, Illingworth A, Rosse W, Sutherland D, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry Part B Clin Cytom 2010;78B:211-30.
23. Richards SJ, Barnett D. The role of flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria in the clinical laboratory. Clin Lab Med 2007;27:577-90. (Pubitemid 47068815)
24. Röth A, Hock C, Konik A, Christoph S, Dührsen U. Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena. Int J Hematol 2011;93:704-14.
25. Brodsky RA, Hu R. PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis. Leuk Lymphoma 2006;47:1215-21. (Pubitemid 44269626)
26. Maciejewski JP, Rivera C, Kook H, Dunn D, Young NS. Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones. Br J Haematol 2001;115:1015-22. (Pubitemid 34042927)
27. Nebe T, Schubert J, Gutensohn K, Schrezenmeier H. Flow cytometric analysis of GPI-deficient cells for the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH). J Lab Med 2003;27:257-65. (Pubitemid 36988427)
28. Meyers G, Weitz I, Lamy T, Cahn JY, Kroon HA, Severino B, et al. Disease-related symptoms reported across a broad population of patients with paroxysmal nocturnal haemoglobinuria. Blood 2007;110:Abstract 3683.
29. Hillmen P, Elebute MO, Kelly R, Urbano-Ispizua A, Rother RP, Fu CL, et al. High incidence of progression to chronic renal insuf-ficiency in patients with paroxysmal nocturnal hemo globinuria (PNH). Blood 2007;110:Abstract and Poster 3678.
30. Dacie J V, Lewis SM. Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol 1972;5:3-23.
31. Röth A, Peine S, Dührsen U. Paroxysmal nocturnalhemoglobinuria turning Coombs-positive. Int J Hematol 2010;91:159-60.
32. Höchsmann B, Leichtle R, Zabern I von, Kaiser S, Flegel WA, Schrezenmeier H. Paroxysmal nocturnal hemoglobinuria (PNH) and targeted therapy with the C5 antibody Eculizumab-Lessons for transfusion medicine. Vo x Sang 2011 Sep 19; [epub ahead of print].
33. Risitano AM, Notaro R, Marando L, Serio B, Ranaldi D, Seneca E, et al. Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood 2009;113:4094-100.
34. Bettelheim P, Nebe C, Panse J, Röth A, Schubert J, Schrezenmeier H. Konsensusmeeting Diagnostik der PNH 24.11.2010 München.
35. Sutherland DR, Kueck N, Azcona-Olivera J, Anderson T, Acton E, Barth D, et al. Use of FLAER-based WBC assay in the primary screening of PNH clones. Am J Clin Pathol 2009;132:564-72.
36. Höchsmann B, Rojewski M, Schrezenmeier H. Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes. Ann Hematol 2011;90:887-99.
37. Richards SJ, Whitby I, Cullen MJ, Dickinson AJ, Granger V, Reilly JT, et al. Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry. Cytometry B Clin Cytom 2008;76:47-55.
38. Sutherland DR, Kuek N, Davidson J, Barth D, Chang H, Yeo E, et al. Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B Clin Cytom 2007;72:167-77. (Pubitemid 46676749)
39. Olteanu H, Karandikar NJ, McKenna RW, Xu Y. Differential usefulness of various markers in the flowcytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow. Am J Clin Pathol 2006;126:781-8. (Pubitemid 44707629)
40. Ariel O, Kukultansky T, Raz N, Hollander N. Distinct membrane localization and kinase association of the two isoforms CD58. Cell Signal 2004;16:667-73. (Pubitemid 38490548)
41. Navenot JM, Bernard D, Harousseau JL, Muller JY, Blanchard D. Expression of glycosyl-phosphatidylinositol-linked glycopro-teins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies. Leuk Lymphoma 1996;21: 143-51.
42. Schubert J, Brümmendorf T, Schrezenmeier H, Röth A. Leitlinie Paroxysmale Nächtliche Hämoglobinurie 2011. http://www.dgho-onkopedia. de/onkopedia/leitlinien/paroxysmale-naechtliche-haemoglobinurie-pnh. Accessed June 13, 2011.